TY - JOUR
T1 - Computer-aided diagnosis improves characterization of Barrett's neoplasia by general endoscopists (with video)
AU - Jukema, Jelmer B.
AU - Kusters, Carolus H.J.
AU - Jong, Martijn
AU - Fockens, Kiki N.
AU - Boers, Tim G.
AU - van der Putten, Joost A.
AU - Pouw, Roos E.
AU - Duits, Lucas C.
AU - Weusten, Bas L.
AU - Herrero, Lorenza Alvarez
AU - Houben, Martin H.
AU - Nagengast, Wouter B.
AU - Westerhof, Jessie
AU - Alkhalaf, Alaa
AU - Mallant-Hent, Rosalie C.
AU - Scholten, Pieter
AU - Ragunath, Krish
AU - Seewald, Stefan
AU - Elbe, Peter
AU - Baldaque-Silva, Francisco
AU - Barret, Maximilien
AU - Ortiz Fernández-Sordo, Jacobo
AU - Moral Villarejo, Guiomar
AU - Pech, Oliver
AU - Beyna, Torsten
AU - Montazeri, Nahid S.M.
AU - der Sommen, Fons van
AU - de With, Peter H.
AU - de Groof, Albert J.
AU - Bergman, Jacques J.
N1 - Publisher Copyright:
© 2024 American Society for Gastrointestinal Endoscopy
PY - 2024/10
Y1 - 2024/10
N2 - Background and Aims: Characterization of visible abnormalities in patients with Barrett's esophagus (BE) can be challenging, especially for inexperienced endoscopists. This results in suboptimal diagnostic accuracy and poor interobserver agreement. Computer-aided diagnosis (CADx) systems may assist endoscopists. We aimed to develop, validate, and benchmark a CADx system for BE neoplasia. Methods: The CADx system received pretraining with ImageNet and then consecutive domain-specific pretraining with GastroNet, which includes 5 million endoscopic images. It was subsequently trained and internally validated using 1758 narrow-band imaging (NBI) images of early BE neoplasia (352 patients) and 1838 NBI images of nondysplastic BE (173 patients) from 8 international centers. CADx was tested prospectively on corresponding image and video test sets with 30 cases (20 patients) of BE neoplasia and 60 cases (31 patients) of nondysplastic BE. The test set was benchmarked by 44 general endoscopists in 2 phases (phase 1, no CADx assistance; phase 2, with CADx assistance). Ten international BE experts provided additional benchmark performance. Results: Stand-alone sensitivity and specificity of the CADx system were 100% and 98% for images and 93% and 96% for videos, respectively. CADx outperformed general endoscopists without CADx assistance in terms of sensitivity (P = .04). Sensitivity and specificity of general endoscopists increased from 84% to 96% and 90% to 98% with CAD assistance (P < .001). CADx assistance increased endoscopists’ confidence in characterization (P < .001). CADx performance was similar to that of the BE experts. Conclusions: CADx assistance significantly increased characterization performance of BE neoplasia by general endoscopists to the level of expert endoscopists. The use of this CADx system may thereby improve daily Barrett surveillance.
AB - Background and Aims: Characterization of visible abnormalities in patients with Barrett's esophagus (BE) can be challenging, especially for inexperienced endoscopists. This results in suboptimal diagnostic accuracy and poor interobserver agreement. Computer-aided diagnosis (CADx) systems may assist endoscopists. We aimed to develop, validate, and benchmark a CADx system for BE neoplasia. Methods: The CADx system received pretraining with ImageNet and then consecutive domain-specific pretraining with GastroNet, which includes 5 million endoscopic images. It was subsequently trained and internally validated using 1758 narrow-band imaging (NBI) images of early BE neoplasia (352 patients) and 1838 NBI images of nondysplastic BE (173 patients) from 8 international centers. CADx was tested prospectively on corresponding image and video test sets with 30 cases (20 patients) of BE neoplasia and 60 cases (31 patients) of nondysplastic BE. The test set was benchmarked by 44 general endoscopists in 2 phases (phase 1, no CADx assistance; phase 2, with CADx assistance). Ten international BE experts provided additional benchmark performance. Results: Stand-alone sensitivity and specificity of the CADx system were 100% and 98% for images and 93% and 96% for videos, respectively. CADx outperformed general endoscopists without CADx assistance in terms of sensitivity (P = .04). Sensitivity and specificity of general endoscopists increased from 84% to 96% and 90% to 98% with CAD assistance (P < .001). CADx assistance increased endoscopists’ confidence in characterization (P < .001). CADx performance was similar to that of the BE experts. Conclusions: CADx assistance significantly increased characterization performance of BE neoplasia by general endoscopists to the level of expert endoscopists. The use of this CADx system may thereby improve daily Barrett surveillance.
UR - https://www.scopus.com/pages/publications/85201584235
U2 - 10.1016/j.gie.2024.04.013
DO - 10.1016/j.gie.2024.04.013
M3 - Article
C2 - 38636819
AN - SCOPUS:85201584235
SN - 0016-5107
VL - 100
SP - 616-625.e8
JO - Gastrointestinal Endoscopy
JF - Gastrointestinal Endoscopy
IS - 4
ER -